Home » FDA: Keep Unsolicited Off-Label Communications Private, Narrow
FDA: Keep Unsolicited Off-Label Communications Private, Narrow
Drugmakers responding to unsolicited requests for off-label product information are urged to keep conversations private and specific to the requester’s inquiry, according to a new draft FDA guidance.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May